The Food and Drug Administration advisory committee plans to hold a meeting on June 10 to discuss authorizing COVID-19 vaccines for use in pediatric populations. Pfizer Inc.’s is the only authorized vaccine that is available to 16 and 17-year-olds at this time. The company is currently waiting for word from the FDA about whether it will authorize the same vaccine for 12 to 15-year-olds, which would make it the first vaccine authorized for use in this group of teens. During the meeting, FDA officials are also expected to share details about what they expect to see in applications to authorize and approve these vaccines for use in children. The advisory committee will not discuss specific vaccines, the regulator said.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
